Discover
COCH
Envoy Medical, Inc.
0.79
1 x 0.64
1 x 0.73
bid
ask
-
0.00
0.24%
1 @ 04:00 AM
0.79 -0.00 (0.01%)
| Ytd | 19.53% | |
| 1y | -46.97% |
0.77
day range
0.80
0.36
52 week range
1.89
| Open | 0.80 | Prev Close | 0.79 | Low | 0.77 | High | 0.80 | Mkt Cap | 60.85M |
| Vol | 254.75K | Avg Vol | 324.60K | EPS | -1.02 | P/E | N/A | Forward P/E | -1.43 |
| Beta | 2.36 | Short Ratio | 1.75 | Inst. Own | 6.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.68 | 200-d Avg | 0.74 | 1yr Est | 6.50 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-14 | 2024-09 | -0.27 | -0.37 | -0.1 | -37.04% |
| 2024-08-12 | 2024-06 | -0.24 | N/A | N/A | N/A |
| 2024-08-12 | 2024-06 | -0.24 | -0.27 | -0.03 | -12.50% |
| 2024-05-15 | 2024-03 | -0.19 | N/A | N/A | N/A |
| 2024-05-15 | 2024-03 | -0.19 | -0.32 | -0.13 | -68.42% |
| 2024-04-05 | 2023-12 | -0.19 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-12-06 | Ascendiant Capital | Upgrade | Buy | Buy |
| 2024-10-14 | Brookline Capital | Upgrade | Buy | |
| 2024-09-03 | Ascendiant Capital | Upgrade | Buy | Buy |
| 2024-06-24 | Ascendiant Capital | Upgrade | Buy | |
| 2024-04-03 | Lake Street | Upgrade | Buy | Buy |
| 2023-12-21 | Northland Capital Markets | Upgrade | Outperform |
Profile
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-09-28 | ANZU SPAC GP I L.L.C. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Conversion of Exercise of derivative security |
| 2023-09-28 | DEWBREY DIANE L | Director | 25.00K | Conversion of Exercise of derivative security |
| 2023-09-28 | HIRSCH DANIEL J | Chief Financial Officer | 25.00K | Conversion of Exercise of derivative security |
| 2023-09-28 | HUSKINS PRIYA CHERIAN | Director | 25.00K | Conversion of Exercise of derivative security |
| 2023-09-28 | KANTOR SUSAN J. | Director | 25.00K | Conversion of Exercise of derivative security |
| 2023-11-20 | LUCAS BRENT T | Chief Executive Officer | 131.34K | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Atlas Merchant Capital LLC | 555.53K | 888.84K | 2.74% |
| 2024-09-29 | Vanguard Group Inc | 185.96K | 297.54K | 0.92% |
| 2024-09-29 | Geode Capital Management, LLC | 88.54K | 141.67K | 0.44% |
| 2024-09-29 | HighPoint Advisor Group LLC | 38.66K | 61.86K | 0.19% |
| 2024-09-29 | Corient Private Wealth LLC | 38.16K | 61.06K | 0.19% |
| 2024-09-29 | Morgan Stanley | 31.54K | 50.47K | 0.16% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 112.14K | 179.42K | 0.55% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 70.03K | 112.05K | 0.35% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 39.48K | 63.17K | 0.20% |
| 2024-10-30 | Fidelity Total Market Index Fund | 13.28K | 21.24K | 0.07% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 14.69K | 23.51K | 0.07% |
| 2024-10-30 | iShares Micro Cap ETF | 13.65K | 21.85K | 0.07% |